These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3822 related articles for article (PubMed ID: 7515293)

  • 1. Vascular endothelial growth factor and its receptors.
    Neufeld G; Tessler S; Gitay-Goren H; Cohen T; Levi BZ
    Prog Growth Factor Res; 1994; 5(1):89-97. PubMed ID: 7515293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells.
    Cohen T; Gitay-Goren H; Sharon R; Shibuya M; Halaban R; Levi BZ; Neufeld G
    J Biol Chem; 1995 May; 270(19):11322-6. PubMed ID: 7744769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain.
    Soker S; Fidder H; Neufeld G; Klagsbrun M
    J Biol Chem; 1996 Mar; 271(10):5761-7. PubMed ID: 8621443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms.
    Gengrinovitch S; Greenberg SM; Cohen T; Gitay-Goren H; Rockwell P; Maione TE; Levi BZ; Neufeld G
    J Biol Chem; 1995 Jun; 270(25):15059-65. PubMed ID: 7797488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells.
    Gitay-Goren H; Cohen T; Tessler S; Soker S; Gengrinovitch S; Rockwell P; Klagsbrun M; Levi BZ; Neufeld G
    J Biol Chem; 1996 Mar; 271(10):5519-23. PubMed ID: 8621410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma.
    Brown LF; Tognazzi K; Dvorak HF; Harrist TJ
    Am J Pathol; 1996 Apr; 148(4):1065-74. PubMed ID: 8644848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors.
    Tessler S; Rockwell P; Hicklin D; Cohen T; Levi BZ; Witte L; Lemischka IR; Neufeld G
    J Biol Chem; 1994 Apr; 269(17):12456-61. PubMed ID: 8175651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The angiogenic pathway "vascular endothelial growth factor/flk-1(KDR)-receptor" in rheumatoid arthritis and osteoarthritis.
    Giatromanolaki A; Sivridis E; Athanassou N; Zois E; Thorpe PE; Brekken RA; Gatter KC; Harris AL; Koukourakis IM; Koukourakis MI
    J Pathol; 2001 May; 194(1):101-8. PubMed ID: 11329148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of vascular endothelial growth factor and its receptor mRNAs in the mouse uterus around the time of implantation.
    Chakraborty I; Das SK; Dey SK
    J Endocrinol; 1995 Nov; 147(2):339-52. PubMed ID: 7490564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring VEGF-Flk-1 activity and consequences of VEGF-Flk-1 targeting in vivo using intravital microscopy: clinical applications.
    Vajkoczy P; Thurnher A; Hirth KP; Schilling L; Schmiedek P; Ullrich A; Menger MD
    Oncologist; 2000; 5 Suppl 1():16-9. PubMed ID: 10804086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a soluble vascular endothelial growth factor receptor-immunoglobulin chimera.
    Kaplan JB; Sridharan L; Zaccardi JA; Dougher-Vermazen M; Terman BI
    Growth Factors; 1997; 14(4):243-56. PubMed ID: 9386989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a heparin binding peptide on the extracellular domain of the KDR VEGF receptor.
    Dougher AM; Wasserstrom H; Torley L; Shridaran L; Westdock P; Hileman RE; Fromm JR; Anderberg R; Lyman S; Linhardt RJ; Kaplan J; Terman BI
    Growth Factors; 1997; 14(4):257-68. PubMed ID: 9386990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours.
    Stitt AW; Simpson DA; Boocock C; Gardiner TA; Murphy GM; Archer DB
    J Pathol; 1998 Nov; 186(3):306-12. PubMed ID: 10211121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression.
    Brogi E; Schatteman G; Wu T; Kim EA; Varticovski L; Keyt B; Isner JM
    J Clin Invest; 1996 Jan; 97(2):469-76. PubMed ID: 8567969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor and its receptors in normal human testicular tissue.
    Ergün S; Kiliç N; Fiedler W; Mukhopadhyay AK
    Mol Cell Endocrinol; 1997 Jul; 131(1):9-20. PubMed ID: 9256359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.
    Soker S; Takashima S; Miao HQ; Neufeld G; Klagsbrun M
    Cell; 1998 Mar; 92(6):735-45. PubMed ID: 9529250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of vascular endothelial growth factor and its receptor, KDR, following retinal ischemia-reperfusion injury in the rat.
    Ogata N; Yamanaka R; Yamamoto C; Miyashiro M; Kimoto T; Takahashi K; Maruyama K; Uyama M
    Curr Eye Res; 1998 Nov; 17(11):1087-96. PubMed ID: 9846628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variations in the size and sulfation of heparin modulate the effect of heparin on the binding of VEGF165 to its receptors.
    Soker S; Goldstaub D; Svahn CM; Vlodavsky I; Levi BZ; Neufeld G
    Biochem Biophys Res Commun; 1994 Sep; 203(2):1339-47. PubMed ID: 7522446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic changes in expression of mRNA of vascular endothelial growth factor, its receptors Flt-1 and KDR/Flk-1, and Ets-1 in human corpora lutea.
    Endo T; Kitajima Y; Nishikawa A; Manase K; Shibuya M; Kudo R
    Fertil Steril; 2001 Oct; 76(4):762-8. PubMed ID: 11591411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.
    Sawano A; Takahashi T; Yamaguchi S; Aonuma M; Shibuya M
    Cell Growth Differ; 1996 Feb; 7(2):213-21. PubMed ID: 8822205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 192.